abstract |
The present invention relates to compounds of formula I, stereoisomers, enantiomers, pharmaceutically acceptable salts or amino acid conjugates thereof, wherein the variables are as defined herein; and farnesoids It relates to pharmaceutical compositions useful as modulators of X receptor (FXR) activity. |